China’s AI-developed weight loss drug may help fight obesity, diabetes

A team of Chinese scientists harnessed the power of artificial intelligence (AI) to develop a new weight-loss drug that can not only tackle rising obesity but also treat Type 2 diabetes. Developed by AI-powered drug discovery company MindRank, the drug called MDR-001 works by binding to the glucagon-like peptide-1 receptor (GLP-1-R) — a well-established drug target, the South China Morning Post (SCMP) reported. By binding to this receptor, the drug stimulates insulin release from the pancreas, which helps to lower blood sugar levels and reduce weight.